Chewing gum containing colloidal bismuth subcitrate

Details Chewing gum containing colloidal bismuth subcitrate Chewing gum containing colloidal bismuth subcitrate

1996-11-01

1998-11-10

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

424441, 424 48, 424 52, A61K 968

Patent

active

058340025

ABSTRACT:
The invention provides a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a bismuth-containing gum which when chewed multiple times per day, over the period of two weeks, is effective in reducing peptic ulcers by eradicating H. pylori. The chewing gum is also effective in eliminating forms of halitosis. The chewing gum does not have undesirable side effects, unpleasant taste and poor chewing characteristics.

REFERENCES:
patent: 3011949 (1961-12-01), Bilotti
patent: 3352689 (1967-11-01), Bilotti
patent: 3824006 (1974-07-01), Voit
patent: 3929449 (1975-12-01), Hedrich
patent: 3943258 (1976-03-01), Bahoshy et al.
patent: 3973041 (1976-08-01), DuRoss
patent: 4055655 (1977-10-01), Maurer et al.
patent: 4153685 (1979-05-01), Serfontein
patent: 4180473 (1979-12-01), Maurer et al.
patent: 4208431 (1980-06-01), Friello et al.
patent: 4217368 (1980-08-01), Witzel et al.
patent: 4514421 (1985-04-01), Herschler
patent: 4652444 (1987-03-01), Maurer
patent: 4670245 (1987-06-01), Vasquez
patent: 4680309 (1987-07-01), Maurer
patent: 4801454 (1989-01-01), Coveney
patent: 4801608 (1989-01-01), Bos et al.
patent: 4822597 (1989-04-01), Faust et al.
patent: 4879116 (1989-11-01), Fox et al.
patent: 4940695 (1990-07-01), Coveney et al.
patent: 4956386 (1990-09-01), McLoughlin et al.
patent: 4965382 (1990-10-01), Furlan
patent: 4975270 (1990-12-01), Kehoe
patent: 5013560 (1991-05-01), Stentz et al.
patent: 5017367 (1991-05-01), Stojkoski
patent: 5093342 (1992-03-01), Tomoi et al.
patent: 5192752 (1993-03-01), Chapura
patent: 5256684 (1993-10-01), Marshall
patent: 5264222 (1993-11-01), Groenendaal et al.
patent: 5286492 (1994-02-01), Dettmar
patent: 5294433 (1994-03-01), Singer
patent: 5352679 (1994-10-01), Ferrieri et al.
patent: 5372815 (1994-12-01), Hodutu
patent: 5385739 (1995-01-01), Debregeas et al.
patent: 5403830 (1995-04-01), Place
patent: 5425948 (1995-06-01), Olivieri
patent: 5466681 (1995-11-01), Krivan et al.
patent: 5476669 (1995-12-01), Borody
patent: 5514660 (1996-05-01), Zopf
patent: 5536510 (1996-07-01), Tyrpin et al.
patent: 5601848 (1997-02-01), Marshall
Beil et al., "Studies on the Mechanism of Action of Colloidal Bismuth Subcitrate," Pharmacology 47:135-140 (1993).
Beil et al., "Studies on the Mechanism of Action of Colloidal Bismuth Subcitrate," Pharmacology 47:141-144 (1993).
Hosking et al., "Duodenal Ulcer Healing by Eradication of Helicobacter Pylori Without Anti-acid Treatment: Randomised Controlled Trial," The Lancet 343:508-510 (1994).
Lee, "The Mode of Action of Colloidal Bismuth Subcitrate," Scand. J. Gastroenterol 26(185):1-6 (1991).
Norfleet, "Helicobacter Halitosis", J. Clin. Gastroenterol, vol. 16, No. 3, 1993.
Rosenberg et al., "Day-Long Reduction of Oral Malodor by a Two-Phase Oil: Water Mouthrinse as Compared to Chlorhexidine and Placebo Rinses", J. Periodontol, 63(1): 39-43 (1982).
Tiomny et al., "Halitosis and Helicobacter Pylori", J. Clin. Gastroenterol 15(3):236-237 (1992).
Bosy et al., "Relationship of Oral Malodor to Periodontitus: Evidence of Independence in Discrete Subpopulations", J. Periodontol, 65(1):37-46 (1992).
De Boever et al., "Assessing the Contribution of Anaerobic Microflora of the Tongue to Oral Malodor", JADA, vol. 126, Oct., 1995.
Kleinberg et al., "Salivary and Metabolic Factors Involved in Oral Malodor Formation", J. Periodontol, 63(9): 768-775 (1992).
1994 Annual Report for Applied Microbiology, Inc.; distributed with notice of Annual Shareholders Meeting which was mailed Feb., 1995.
Axton, A.T.R., Campyobacter pylori--Therapy Review, Scand. J. Gastroenterol., 1989, 24 (suppl 160), 35-38.
Benet, L.Z., Safety and Pharmacokinetics: Colloidal Bismuth Subcitrate, Scand. J. Gasstroenterol., 1991, 26 (Suppl 185), 29-35.
Boyd, E.J.S. et al., Recurrent ulcer disease, Gastroenterology Clinics of America. Helicobacter pylori Infection, Dooley CP, Cohen, H. Guest Editors, vol. 22, No. 1, pp. 14-42, Mar. 1993.
Desai, H.G. et al., Dental Plaque: A Permanent Reservoir of Helicobacter Pylori?, Scand. J. Gastroenterol., 1991, 26, 1205-1208.
Dobrilla, G. et al., Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials, Gut., 1988, 29, 181-187.
Goh, K.L. et al., Helicobacter pylori Infection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate, Scand. J. Gastroenterol., 1991, 26, 1123-1131.
Goodwin, C.S. et al., The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis, J. Antimicrobial Chemotherapy (1986) 17, 309-314.
Jensen, L. et al., Chewing gum and lozenges as delivery systems for noscapine, Acta Pharm. Nord. 3(4):219-222 (1991).
Jones, D.B. et al., Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs, Gut. 1987, 28, 1120-1127.
Lambert, I., The Lancet, vol. 341, Apr. 1993, p. 957.
Lambert, J.R., Clinical Indications and Efficacy of Colloidal Bismuth Subcitrate, Scand. J. Gastroenterol., 1991, 26 (suppl 185), 13-21.
Lambert, T. et al., Susceptibility of Campylobacter pyloridis to 20 Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, Sep. 1986, pp. 510-511.
Lashner, B.A. et al., Testing Nicotine Gum for Ulcerative Colitis Patients, Digestive Diseases and Sciences, vol. 35, No. 7 (Jul. 1990), pp. 827-832.
Lees, V.C. et al., A freeze-injured skin graft model for the quantitative study of basic fibroblast growth factor and other promoters of angiogenesis in wound healing, British Journal of Plastic Surgery (1994), 47, 349-359.
Marshall, Treatment Strategies for Helicobacter Pylori Infection, Gastroenterology Clinics of America. Helicobacter pylori Infection, Dooley CP, Cohen, H. Guest Editors. vol. 22, No. 1, pp. 186-195.
Matuszewska, B. et al., Acidic Fibroblast Growth Factor: Evaluation of Topical Formulations in a Diabetic Mouse Wound Healing Model, Pharmaceutical Research, vol. 11, No. 1, 1994, pp. 65-71.
McNulty, C. et al., Susecptibility of Clinical Isolates of Campylobacter pyloridis to 11 Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, vol. 28, No. 6, Dec. 1985, pp. 837-838.
Mustofa et al., Pharmacokinetics of metronidazole in saliva, International Journal of Clinical Pharmacology, Therapy, and Toxicology, Dec. 1991, 29(12):474-478.
Nguyen, A. et al., Detection of Helicobacter pylori in Dental Plaque by Reverse Transcription-Polymerase Chain Reaction, J. Clin. Microbiol., vol. 31, No. 4, pp. 783-787 (1993).
Wagner, S. et al., Bismuth subsalicylate in the treatment of H.sub.2 blocker resistant duodenal ulcers: role of Helicobacter pylori, Gut., 1992, 33, 179-183.
Wieriks, J. et al., Pharmacological Properties of Colloidal Bismuth Subcitrate (CBS, DE-NOL.RTM.), Scand. J. Gastroenterol., 1982, 17, Suppl 80, 11-16.
Wormsley, K., Relapse of duodenoal ulcer, British Medical Journal, vol. 293, 1986, p. 1501.
Wu, L. et al., Platelet-derived Growth Factor-BB Accelerates Wound Closure in a New Mesentery Culture Model Without Macrophages, Annals of Plastic Surgery, vol. 33, No. 2, Aug. 1994, p. 155.
Konturek et al., Scandanavian Journal of Gastroenterology 21 (Suppl. 122) :6-10 (1986).
Konturek et al., Digestion 37 (Suppl. 2) :8-15 (1987).
Lee et al., Lancet 1:1299-1301 (1985).
Lee, S.P., Scandinavian Journal of Gastroenterology 26 (Supp 1985) :1-6 (1991).
Logan et al., The Lancet 338:1249-1252 (1991).
O'Connor et al., Gut 30:436-442 (1989).
Olsson et al., The Lancet 341:956-957 (1993).
Parsonnet, J., Gastroenterology Clinics of North America 22(1) :89-104 (1993).
Recavarren-Arce et al., Scandanavian Journal of Gastroenterology 26 (Suppl. 181) :51-57 (1991).
Reed et al., Iarc Scientific Publications 105:139-142 (1991).
Schorah et al., Clin Nutr 53:287S-293S (1991).
Sobala et al., Gut 32:1415-1418 (1991).
Sobala et al., Gastroenterology 97:357-363 (1989).
Abraham et al., Indian Journal of Gastroenterology 9(4):265-269 (1990).
Bianchi et al., The British Society of Gastroenterolo

Affiliated with

Also associated with

Rating

Chewing gum containing colloidal bismuth subcitrate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chewing gum containing colloidal bismuth subcitrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chewing gum containing colloidal bismuth subcitrate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1514189